5 Tailwinds That Could Send Alimentation Couche Tard Inc. Flying Over the Long Term

Impatient investors are selling Alimentation Couche Tard Inc. (TSX:ATD.B) right now, but here’s why this is a huge mistake.

Alimentation Couche Tard Inc. (TSX:ATD.B) took a huge hit on the chin on Thursday as the stock tumbled 3.57% with no real negative news being released. Couche Tard is an incredible earnings-growth story that appears to be ripe for a breakout sometime over the next year. Couche Tard has struggled to sustain a rally past its $60 level of resistance, but I think a few promising earnings reports could be the trigger that sends shares flying to higher levels.

Couche Tard has an incredible management team that is always on the hunt for opportunities to create long-term value for shareholders. The global convenience store industry is still very fragmented. Going forward, there are many growth prospects in foreign and domestic markets that could sustain a compound annual growth rate in the high double digits.

Here are five potential tailwinds that the company may ride over the long term.

U.S. stores set to benefit from strengthening economy

Couche Tard has way too many tailwinds to be trading flat right now. The CST Brands deal beefs up the company’s U.S. exposure. Couche Tard will benefit from a strengthening U.S. economy once the Trump administration’s pro-business promises are put in place.

CST Brands acquisition synergies

The CST Brands deal got the green light under the condition that Couche Tard sells about 71 of its locations to another operator. The deal is going to give earnings a huge bump. Over the next few years, there are many synergy opportunities that will be unlocked that will make a significant impact to the company’ bottom line.

Asian growth prospects

This is the tailwind that I believe many investors may overlook. Couche Tard founder Alain Bouchard stated that the company is looking into the Asian markets for growth opportunities.

Many Asian countries, including Vietnam and the Philippines, are set to see compound annual growth rates as high as 37.4% according IGD Research.

That’s a huge amount of growth, and Couche Tard is positioning itself to get a front-row seat to these markets.

Couche Tard could sell cannabis in Quebec

The management team is aggressively making moves that will allow its Quebec Couche Tard locations to sell cannabis once it becomes legal. The management team hired Marie-Eve Bedard, a lobbyist, to get Couche Tard at the forefront of what I believe is a gigantic opportunity.

Cannabis sales across Canada? The U.S.?

This is a big question mark right now, but it’s definitely some interesting food for thought. Many investors have been focusing their efforts to invest in Canadian cannabis producers, but they have neglected the potential for distributors.

Nobody knows exactly how cannabis will be distributed once it’s legalized. There’s still a taboo surrounding the subject. Some pundits believe cannabis will be distributed through liquor stores, and others believe dispensaries will be the exclusive distributor of the drug.

I think it’s not too far-fetched to look to convenience stores to become distributors of cannabis. As the taboo fades, I believe regulators may become more open to this means of cannabis distribution, and if Couche Tard gets the green light, shares will skyrocket into the atmosphere.

Of course, nobody knows when or if this will happen, so this tailwind is speculative for now.

Bottom line

These are just five potential tailwinds that could make Couche Tard a huge winner over the next five years and beyond. Although the stock has slowed down, the growth prospects have not. For a stock with this much growth potential, I believe a 22.96 price-to-earnings multiple is a very small price to pay.

Stay smart. Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette owns shares of Alimentation Couche Tard Inc. Alimentation Couche Tard Inc. is a recommendation of Stock Advisor Canada.

More on Investing

analyze data
Dividend Stocks

4 Canadian Stocks to Buy Now and Hold for Life

So you have an investment portfolio, but it's all in just a few stocks? If you need to diversify, here…

Read more »

woman looks at iPhone
Dividend Stocks

Want to earn the $1,364.60 Maximum Monthly OAS Benefit? Here’s How

Old Age Security (OAS) offers over $1,300 in benefits, but not everyone is actually receiving this. So how can Canadians…

Read more »

A Canada Pension Plan Statement of Contributions with a 100 dollar banknote and dollar coins.
Dividend Stocks

CPP Inflation Adjustment 2025: Here’s How Much You Could Get

The CPP's inflation adjustment isn't very large, but you can supplement CPP with dividend stocks like Enbridge Inc (TSX:ENB).

Read more »

RRSP (Registered Retirement Savings Plan) on wooden blocks and Canadian one hundred dollar bills.
Investing

RRSP Investors: Buy These Top Dividend Stocks for Total Returns

These two U.S. dividend king stocks are excellent holdings for an RRSP.

Read more »

RRSP Canadian Registered Retirement Savings Plan concept
Dividend Stocks

The Average RRSP Balance Isn’t Enough: Here’s How to Boost it

While it might sound like a lot, the RRSP average just isn't going to cut it for more retirees. So…

Read more »

green power renewable energy
Dividend Stocks

Forget Enbridge: Buy This Magnificent Utilities Stock Instead

Investors seeking higher growth in a solid utility stock should consider this stock over Enbridge. Here's why!

Read more »

potted green plant grows up in arrow shape
Investing

Growth Spurt: 3 TSX Stocks Set to Skyrocket

Given the favourable market environment and healthy growth prospects, these three growth stocks could deliver superior returns in the long…

Read more »

healthcare pharma
Investing

Is it Finally the Right Time to Buy WELL Health Technologies Stock?

With WELL Health Technologies trading unbelievably cheap, yet continuing to grow its profitability, is now the ideal time to own…

Read more »